Richard Hart

Richard Hart is an accomplished professional in business development within the biopharmaceutical industry, currently serving as Executive Director of Business Development Europe at WuXi Biologics since January 2020. Previously, Richard held key positions including Director of Business Development at Leaf Expression Systems, Director at Richard Hart Associates, and Director Global Business Development at Stelis Biopharma. Extensive experience spans roles at Syngene International Limited, Stratophase Ltd, Capsugel, Baxter Healthcare, CMC Biologics, and Fujifilm Diosynth Biotechnologies. Richard holds a BSc in Biology from Queen Mary University of London and an MBA from Open Business School.